Skip to main content
. 2016 Jun 18;7(30):47418–47430. doi: 10.18632/oncotarget.10163

Figure 1. Normal and overexpressed tumors at the protein and mRNA levels for EGFR, MET and CDK6.

Figure 1

. Immunohistochemical staining for EGFR (A, B), MET (C, D) and CDK6 (E, F) proteins in HNSCC tumors. Examples of three tumors with EGFR (A), MET (C) and CDK6 (E) normal mRNA-expressions and three tumors with EGFR (B), MET (D) and CDK6 (F) mRNA-overexpressions. Intense EGFR (B), MET (D) and CDK6 (F) immunoreactivity was found in tumor epithelial cells from the EGFR, MET, CK6 mRNA-overexpressing tumors but not in cells from the tumor without EGFR, MET, CK6 mRNA-overexpression (A, C, E) (original magnification × 50).